Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Cannabidiol on Symptoms of Alzheimer's Disease
IRCT20251208068253N3Phase 3Recruiting
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of cannabidiol in Alzheimer's disease (AD), sponsored by Mashhad University of Medical Sciences. Started Jul 2026; status: recruiting.
02
Drugs
cannabidiol
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on IRCT20251208068253N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251208068253N3.